Evidence map›Paper›PMID 30865664›Full record

Trial reportPloS one2019

Differential prevalence and geographic distribution of hepatitis C virus genotypes in acute and chronic hepatitis C patients in Vietnam.

Chau Le Ngoc, Thanh Tran Thi Thanh, Phuong Tran Thi Lan, Trinh Nguyen Mai, Trang Nguyen Hoa, Ngoc Nghiem My, Tan Le Van, Hung Le Manh, Phuong Le Thanh, Chau Nguyen Van Vinh and 8 more

Abstract readClinical TrialMulticenter Study
In one paragraph

Trial report in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Cost-Utility Analysis of Direct-Acting Antivirals for Treatment of Chronic Hepatitis C Genotype 1 and 6 in Vietnam.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2020
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Chau Le NgocOxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Thanh Tran Thi ThanhOxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Phuong Tran Thi LanThe Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam.
Trinh Nguyen MaiOxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Trang Nguyen HoaOxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Ngoc Nghiem MyThe Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam.
Tan Le VanOxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Hung Le ManhThe Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam.
Phuong Le ThanhThe Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam.
Chau Nguyen Van VinhThe Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam.
Guy ThwaitesOxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Graham CookeImperial College, London, United Kingdom.
Gabrielle M HeilekRoche Molecular Systems, Inc., Pleasanton, California, United States of America.
Cecilia ShikumaHawaii Center for AIDS, University of Hawaii at Manoa, Honolulu, HI, United States of America.
Thuy LeOxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Stephen BakerOxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Motiur RahmanOxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.ORCID 0000-0002-6702-5355
VIZIONS consortium

Funding

Department of Health 14/02/17Medical Research Council MR/P025064/1Wellcome Trust 204904/Z/16/Z
6 · The paper itself

Abstract

backgroundThe highest burden of disease from hepatitis C virus (HCV) is found in Southeast Asia, but our understanding of the epidemiology of infection in many heavily burdened countries is still limited. In particular, there is relatively little data on acute HCV infection, the outcome of which can be influenced by both viral and host genetics which differ within the region. We studied HCV genotype and IL28B gene polymorphism in a cohort of acute HCV-infected patients in Southern Vietnam alongside two other cohorts of chronic HCV-infected patients to better understand the epidemiology of HCV infection locally and inform the development of programs for therapy with the increasing availability of directly acting antiviral therapy (DAAs).

methodsWe analysed plasma samples from patients with acute and chronic HCV infection, including chronic HCV mono-infection and chronic Human Immunodeficiency Virus (HIV)-HCV coinfection, who enrolled in four epidemiological or clinical research studies. HCV infection was confirmed with RNA testing. The 5' UTR, core and NSB5 regions of HCV RNA positive samples were sequenced, and the genotype and subtype of the viral strains were determined. Host DNA from all HCV positive patients and age- and sex-matched non-HCV-infected control individuals were analysed for IL28B single nucleotide polymorphism (SNP) (rs12979860 and rs8099917). Geolocation of the patients were mapped using QGIS.

results355 HCV antibody positive patients were analysed; 54.6% (194/355) and 46.4% (161/355) were acute and chronic infections, respectively. 50.4% (81/161) and 49.6.4% (80/161) of chronic infections had HCV mono-infection and HIV-HCV coinfection, respectively. 88.7% (315/355) and 10.1% (36/355) of the patients were from southern and central regions of Vietnam, respectively. 92.4% (328/355) of patients were HCV RNA positive, including 86.1% (167/194) acute and 100% (161/161) chronic infections. Genotype could be determined in 98.4% (322/328) patients. Genotypes 1 (56.5%; 182/322) and 6 (33.9%; 109/322) predominated. Genotype 1 including genotype 1a was significantly higher in HIV-HCV coinfected patients compared to acute HCV patients [43.8% (35/80) versus 20.5% (33/167)], (p = <0.001), while genotype 6 was significantly higher in chronic HCV mono-infected patients [(44.4% (36/81) versus 20.0% (16/80)] (p = < 0.004) compared to HIV-HCV coinfected patients. The prevalence of IL28B SNP (rs12979860) homozygous CC was 86.46% (83/96) in control individuals and was significantly higher in acutely-infected compared to chronically-infected patients [93.2 (82/88) versus 76.1% (35/46)] (p = < 0.005).

conclusionHCV genotype 6 is highly prevalent in Vietnam and the high prevalence in treatment naïve chronic HCV patients may results from poor spontaneous clearance of acute HCV infection with genotype 6.

Indexed as

CoinfectionGenotypeHepatitis C, ChronicHIV InfectionsAcute DiseaseAdolescentAdultAgedAged, 80 and overChildChild, PreschoolFemaleHepacivirusHIV-1HumansInfantRNA, Viral

Identifiers

PMID30865664
PMCPMC6415813

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.